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Introduction: Angiosarcoma of bone is an uncommon primary bone neoplasm that is composed of tumor cells
that show endothelial differentiation. This is an aggressive malignancy characterized by frequent local recurrence
and distant metastases. The majority of patients die within one year of diagnosis, and this shows that angiosarcoma
of bone is an aggressive high-grade tumor.
Case presentation: We present the case of a 65-year-old Japanese woman who had primary angiosarcoma of the
proximal humerus with a pathological fracture. An open biopsy confirmed a diagnosis of primary angiosarcoma of
bone. Our patient was treated with neoadjuvant chemotherapy and wide resection. One month after surgery, she
developed multifocal distant metastasis to her liver and spleen.
Conclusions: Angiosarcoma of the humerus is extremely rare. Radiographically, there is no specific finding
associated with angiosarcoma of bone as opposed to other malignant bone tumors. The cornerstone of treatment
is en bloc resection followed by as much adjuvant radiation therapy as possible. However, the role of
chemotherapy remains undefined, and better systemic agents are clearly needed.
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Malignant vascular tumors of bone are very rare and ac-
count for less than 1% of primary malignant bone
tumors. Angiosarcoma is an uncommon neoplasm char-
acterized by rapidly proliferating and extensively infil-
trating anaplastic cells derived from vessels and lining
irregular blood-filled spaces [1]. Skeletal angiosarcoma
generally affects young adults and elderly individuals,
and age distribution shows a wide range with a nearly
equal distribution from the second to the eighth decade
of life [2]. Angiosarcomas tend to affect long tubular
bones of the extremities and the axial skeleton, mainly
the spine. The bones of the lower limb, particularly the
femur and the tibia, are most commonly involved, fol-
lowed by the pelvis, vertebral column, and the bones of
the upper limbs [3,4]. We describe an extremely rare
case of a woman with angiosarcoma of the humerus
who underwent chemotherapy and wide resection.* Correspondence: hidekiy@med.tottori-u.ac.jp
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A 65-year-old Japanese woman fell as she was getting out
of bed and injured her left shoulder. Plain radiograph and
computed tomography (CT) revealed an osteolytic lesion
in her proximal humerus with a wide zone of transition
between the tumor and uninvolved bone (Figures 1 and
2). The cortex of her proximal humerus was thinned, and
a pathological fracture was also seen, but cortical expan-
sion was absent in that lesion. Magnetic resonance im-
aging showed a lesion with low intensity on T1-weighted
images and intermediate intensity on T2-weighted images
(Figure 3). Gadolinium-enhanced T1-weighted images
showed heterogeneous enhancement of the lesion.
Fluorine-18-fluorodeoxyglucose positron emission tomog-
raphy imaging demonstrated no distant metastases. Open
biopsy revealed a tumor composed of anastomosing vas-
cular channels and cystic spaces lined by malignant cells
(Figure 4). Immunohistochemical analysis showed CD31,
CD34, and factor VIII RA positivity, confirming the vascu-
lar origin of the tumor, and a diagnosis of primary angio-
sarcoma of bone was made (Figure 5).
Our patient was treated with three cycles of pre-
operative chemotherapy composed of mesna, doxorubicin,tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Anteroposterior radiograph of the left shoulder shows
a pathological fracture with an osteolytic lesion.
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During the three cycles of pre-operative chemotherapy,
the size of the mass did not change, but her spontaneous
pain decreased.Figure 2 Computed tomography scan shows cortical destruction of th
view. (B) Coronal view.After pre-operative chemotherapy, en bloc resection of
the tumor was performed by extra-articular humeral and
glenoid resection (Figures 6 and 7). The clavicula pro
humero method was initially planned for reconstruction,
but the acromioclavicular joint was collapsed, and the
distal clavicular end detached from surrounding soft tis-
sue during osteotomy of the lower aspect of acromion.
Therefore, reconstruction with this method failed, result-
ing in a flail shoulder. After surgery, our patient did not
wish to receive additional reconstruction surgery and ad-
juvant radiotherapy. Two months after surgery, she had
moderate function according to a Musculoskeletal
Tumor Society and International Symposium on Limb
Salvage [5] evaluation; she had scores of five for pain,
one for function, three for emotional acceptance, one for
positioning of the hand, five for manual dexterity, and
zero for lifting ability. The total score was 15 points
(50%). Our patient did not complain of any pain. Impair-
ment of activity of daily living was slight when a sling
was used.
Histological examination of the excised tumor indi-
cated that the surgical margin was wide in all directions,
and necrosis was observed in more than approximately
90% of the maximum cut surface. After surgery, our
patient’s upper limb was immobilized with a stockinette-
Gilchrist bandage. Four weeks after surgery, CT scans of
her abdomen revealed distant metastases in her liver
and spleen (Figure 8). One cycle of post-operative
chemotherapy using the MAID protocol was performed,
but she discontinued additional post-operative chemo-
therapy. We did not see local recurrence until the final
follow-up. Five months after surgery, she transferred to
another hospital because she had changed residence.e proximal humerus and a pathological fracture. (A) Transverse
Figure 3 Magnetic resonance imaging (MRI) of the left proximal humerus. (A) Sagittal T1-weighted MRI shows a low-signal-intensity tumor
replacing bone marrow. (B) Coronal T2-weighted MRI demonstrates an increase in the signal intensity of the tumor.
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Angiosarcoma of bone is a rare malignant neoplasm
and represents the most malignant end of the
spectrum of vascular tumors. Approximately 6% of all
angiosarcomas are found in bone [2]. To the best of
our knowledge, angiosarcoma of the humerus is ex-
tremely rare; only five cases have been reported in the
literature in English since 1953 [6-10] (Table 1). This
is an aggressive malignancy characterized by frequent
local recurrence and distant metastases. These lesions
occur during the second to the seventh decades of life, al-
though the peak is during the third to fifth decades [11].
Men are affected with twice the frequency of women.Figure 4 A tumor composed of anastomosing vascular
channels and cystic spaces lined by malignant cells is seen.
Stain: hematoxylin and eosin; original magnification: ×200.The most common osseous lesions are the long bones
(approximately 60% of cases), particularly the tibia (23%),
femur (18%), and humerus (13%), as well as the pelvis
(7%) [12]. The two most common symptoms are local
pain and swelling.
Radiographically, there is no specific finding asso-
ciated with angiosarcoma of bone as opposed to
other malignant bone tumors. Lesions are usually
highly destructive and may grow too fast to invoke a
periosteal reaction. They may be eccentric and may
have a purely lytic or mixed lytic sclerotic pattern
[13]. More aggressive features include osseous expan-
sion, cortical permeation, and an associated soft tis-
sue mass [14]. CT and magnetic resonance imaging
characteristics of angiosarcoma may also be non-
specific [14]. In general, pathological fractures of high-
grade primary bone sarcomas occur either spontan-
eously or after minimal trauma. The incidence of
pathological fracture at diagnosis in patients with
angiosarcoma of bone is unknown.
Pathologically, these tumors may contain either
hemangiomatous or lymphangiomatous cellular ele-
ments, which are often difficult or impossible to dis-
tinguish histologically, particularly with higher
degrees of anaplasia. Identification of vascular chan-
nels allows diagnosis; thus, the term angiosarcoma is
preferable to hemangiosarcoma or lymphangiosar-
coma for these malignant vascular neoplasms [15].
Verbeke et al. [16] recently reported that primary
angiosarcoma of bone exhibiting more than three mi-
toses per 10 high-powered fields (HPFs), a prominent
nucleolus, and fewer than five eosinophilic
Figure 5 Immunohistochemical analysis revealed strong staining of tumor cells for CD31, CD34, and factor VIII RA. (A) CD34. (B) CD31.
(C) Factor VIII RA. Original magnification: × 100.
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course and worse outcome, indicating that these
histological criteria have prognostic value.
In angiosarcoma, local recurrence is frequent, prog-
nosis is notoriously poor, and early metastases develop.
Metastases to the lungs and other parenchymal organs
are found in about 66% of cases [15]. It is reported
that the majority of patients die within one year of
diagnosis, and this shows that angiosarcoma of bone is
an aggressive high-grade tumor [17]. In our case, one
month after surgery, multiple distant metastases were
observed, despite three cycles of pre-operative chemo-
therapy (MAID).
The treatment of angiosarcoma is often quite challen-
ging. The cornerstone of treatment is en bloc resection
followed by as much adjuvant radiation therapy aspossible [18]. Surgery combined with immediate post-
operative radiation therapy could be an optimal treat-
ment method, even if complete resection is possible [19].
In our patient, adjuvant radiotherapy was not performed,
because she refused.
The role of chemotherapy remains undefined [19].
Several anticancer drug combinations, including cis-
platin with doxorubicin, cisplatin plus paclitaxel, and
cisplatin plus doxorubicin plus paclitaxel, have been
investigated [20]. Abraham et al. [13] reported that
doxorubicin-based chemotherapy regimens, which are
commonly used for other sarcoma subtypes, have
also been used for angiosarcomas. Patients were gen-
erally treated with doxorubicin-based regimens or
vinorelbine, and 64% of patients had at least a partial
response to at least one regimen. Given these data, a
Figure 6 Immediate post-operative radiograph of the left
shoulder after wide resection.
Figure 7 Excised specimen of the proximal humerus.
(A) Macroscopic appearance of resected specimen. (B) Coronal cut
surface of the specimen.
Figure 8 Contrast-enhanced computed tomography scan
shows metastatic tumors in the liver and spleen (arrows).
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dacarbazine – that is, the MAID protocol – was admi-
nistered to our patient before and after surgery.
However, post-operative CT scans revealed distant me-
tastases in her liver and spleen. Prolonged responses
were uncommon, and better systemic agents are clearly
needed.
Recently, a novel t (1; 14) (p21; q24) translocation
was described in angiosarcoma of bone [21]. To the
best of our knowledge, this is the first cytogenic aber-
ration reported in angiosarcoma of bone. However,
small series have shown the involvement of tumor-
suppressor genes such as p53 and p16, mainly in
angiosarcoma of soft tissue, suggesting a possible role
in tumorigenesis in a subset of angiosarcomas. It is
still unclear whether primary angiosarcoma of bone is
a true separate entity or is similar to primary angio-
sarcoma of deep soft tissues. Further molecular stud-
ies might be required in order to investigate the
different therapeutic targets.
Conclusions
We present an extremely rare case of angiosarcoma
of bone with a pathological fracture. Our case adds to
the limited literature on angiosarcoma of the hu-
merus. The cornerstone of treatment is en bloc resec-
tion followed by as much adjuvant radiation therapy
as possible. However, the role of chemotherapy
remains undefined, and better systemic agents are
clearly needed.
Consent
Written informed consent was obtained from the
patient for publication of this case report and the
Table 1 Reported cases of angiosarcoma of the humerus
Case
number
Reference Patient Radiographic features Treatment Outcome
1 Hasegawa et al.
[8]
48-year-old man A multilocular osteolytic lesion
with undefined margins
and destroyed cortical and
medullary bone
Amputation of the arm at
the level of the scapula
DOD
2 Fukuroku et al.
[7]
55-year-old man Severe bone destruction





3 Voggenreiter et al.
[10]
12-year-old boy ND Wide resection CDF
4 Chen [6] 87-year-old man Expansile lytic lesion
involving the entire diaphysis
of the humerus with a fracture in the distal




5 Mittal et al.
[9]
67-year-old man Erosion of medial cortex





CDF: continuously disease-free; DOD: dead of disease; ND: not documented.
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is available for review by the Editor-in-Chief of this
journal.
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